pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Anti-inflammatory · news · pharmadog
← back to Anti-inflammatory
News mentioning Anti-inflammatory
25
stories
2d
Foghorn cuts 40% of workforce
biospace
5d
Connect’s Dupixent rival reduces COPD attacks by 85%, but misses a secondary goal
fiercebiotech
11d
Opinion: STAT+: A moment of reckoning for preventive cardiology and the precision medicine revolution
stat
13d
Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win
fiercebiotech
25d
NodThera, a decade-old NLRP3 player, plans Phase 3 and a rebrand
endpoints
Aug 27, 26
New data could widen use of AstraZeneca, Amgen immune disease drug
biopharma dive
Aug 27, 26
Generate Bio drops as data accidentally leaked ahead of European conference
biospace
Aug 27, 26
AstraZeneca, Amgen notch another late-stage win for Tezspire, this time in esophagitis
biospace
Aug 25, 26
China’s Haisco forms immunology biotech with up to $1.5B from American VCs
biospace
Aug 18, 26
Regeneron ends eye disease study due to antibody's safety profile
biospace
Aug 18, 26
Regeneron ends eye disease study due to antibody's safety profile
biospace
Aug 10, 26
Arpeggio plays final chord as biotech disbands on poor prospects for Nrf2 program
fiercebiotech
Aug 6, 26
BioVie shares halve on murky Parkinson’s disease readout
biospace
Jul 31, 26
Novo Nordisk rocked by late-stage cardiovascular drug failure
endpoints
Jul 31, 26
STAT+: Novo Nordisk inflammation-targeting drug misses mark in heart disease study
stat
Jul 29, 26
‘We have what we need to grow:’ Biogen CEO happy to ease off the M&A for a while
fiercebiotech
Jul 21, 26
Novartis stays 'geography-agnostic' in dealmaking amid flurry of China deals
biospace
Jul 15, 26
Cassidy grills Trump nominee on past vaccine comments in heated exchange
stat
Jun 18, 26
cAMPfield lands $180M to build gut disease drug
biopharma dive
Jun 18, 26
Biogen adds more immune drugs in $1B buyout of secretive startup RayThera
biopharma dive
Jun 18, 26
Biogen makes up to $1B deal for secretive anti-inflammatory biotech
endpoints
Jun 16, 26
How supplement use changed over decades
stat
Jun 10, 26
Sanofi stops immune drug trial in latest research setback
biopharma dive
May 18, 26
Regeneron immunotherapy combo comes up short in melanoma trial
biopharma dive
Apr 23, 26
Sanofi posts upbeat sales as R&D pressure builds
biopharma dive
